New Key Statistics Module, Z-Score and F-Score
AMEX:IGC Key Ratios
| Market Cap $ M | 36.21 |
| Enterprise Value $ M | 29.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.87 |
| Price/Sales | 25.84 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.26 |
| Beneish M-Score | -5.1 |
| 10-y EBITDA Growth Rate % | -1.40 |
| 5-y EBITDA Growth Rate % | -28.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.57 |
| EV-to-EBITDA | -2.71 |
| PEG | -- |
| Shares Outstanding M | 66.81 |
| Net Margin (%) | -1,163.24 |
| Operating Margin % | -959.46 |
| Pre-tax Margin (%) | -1,163.24 |
| Quick Ratio | 0.86 |
| Current Ratio | 1.85 |
| ROA % (ttm) | -87.65 |
| ROE % (ttm) | -101.64 |
| ROIC % (ttm) | -92.62 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.22 |
IGC Number of Guru Trades
IGC Volume of Guru Trades
Gurus Latest Trades with AMEX:IGC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:IGC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
IGC Pharma Inc Insider Transactions
No Available Data
News about AMEX:IGC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers